NO20073395L - Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer - Google Patents

Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Info

Publication number
NO20073395L
NO20073395L NO20073395A NO20073395A NO20073395L NO 20073395 L NO20073395 L NO 20073395L NO 20073395 A NO20073395 A NO 20073395A NO 20073395 A NO20073395 A NO 20073395A NO 20073395 L NO20073395 L NO 20073395L
Authority
NO
Norway
Prior art keywords
gastric
coating composition
composition containing
resistant
sticking agent
Prior art date
Application number
NO20073395A
Other languages
English (en)
Inventor
George Reyes
Thomas Farrell
Kurt Fegely
Ali Rajabi-Siahboomi
Budhi Simon
Cara Young
Original Assignee
Bpsi Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36588225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073395(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bpsi Holdings Inc filed Critical Bpsi Holdings Inc
Publication of NO20073395L publication Critical patent/NO20073395L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Tørre, enteriske filmbelegningsblandinger og vandige dispersjoner inneholdende de samme er beskrevet. Når de er påført oralt inntakbare substrater som for eksempel orale faste doseformer er filmbeleggene i stand til å hindre at substratene desintegrerer i media med pH verdier fra omtrent 1 til omtrent 4,5 eller høyere verdier. En foretrukket filmbelegningsblanding inneholder et mikronisert mellomprodukt bestående av en akrylharpiks og talkum. Fordelaktig og overraskende inneholder den foretrukne filmbelegningsblanding ikke et alkaliserende middel.
NO20073395A 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer NO20073395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63708304P 2004-12-17 2004-12-17
PCT/US2005/046326 WO2006066264A1 (en) 2004-12-17 2005-12-16 Enteric film coating composition containing enteric polymer micronized with detackifier

Publications (1)

Publication Number Publication Date
NO20073395L true NO20073395L (no) 2007-09-07

Family

ID=36588225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073395A NO20073395L (no) 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Country Status (15)

Country Link
US (1) US20060134216A1 (no)
EP (1) EP1827390A1 (no)
JP (1) JP2008524257A (no)
KR (1) KR20070094627A (no)
CN (1) CN101080217B (no)
AR (1) AR051722A1 (no)
AU (1) AU2005316235A1 (no)
BR (1) BRPI0518575A2 (no)
CA (1) CA2586425A1 (no)
IL (1) IL183579A0 (no)
MX (1) MX2007007221A (no)
NO (1) NO20073395L (no)
TW (1) TW200626185A (no)
WO (1) WO2006066264A1 (no)
ZA (1) ZA200704311B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5661281B2 (ja) * 2006-08-18 2015-01-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングＥｖｏｎｉｋ Ｒｏｅｈｍ ＧｍｂＨ 良好な水溶解性を有する作用物質のための作用物質の制御送達を有する医薬組成物
CN102421423B (zh) 2009-05-12 2014-11-05 Bpsi控股有限责任公司 增强型防潮即释薄膜包衣系统和覆有该包衣的基体
AU2010248061A1 (en) * 2009-05-12 2011-10-27 Bpsi Holdings, Llc. Film coatings containing fine particle size detackifiers and substrates coated therewith
PH12012502153A1 (en) * 2010-04-30 2013-02-04 Takeda Pharmaceuticals Co Enteric tablet
CN103096879B (zh) * 2010-04-30 2014-12-10 武田药品工业株式会社 肠溶片剂
WO2014159814A1 (en) * 2013-03-13 2014-10-02 Patricia Oliver Formulations and tablets for treatment or prevention of neurological disorders
EA201792512A1 (ru) 2015-06-12 2018-06-29 Вэксарт, Инк. Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник
US10758489B2 (en) * 2018-04-12 2020-09-01 Bpsi Holdings Llc Acidifying coatings and disintegration-resistant substrates coated therewith
US11458104B1 (en) 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN116617174B (zh) * 2023-05-12 2024-03-08 石家庄四药有限公司 一种含硫酸氢氯吡格雷和阿司匹林的片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US656457A (en) * 1900-05-11 1900-08-21 Isaac Hirsch Knife.
US2595076A (en) * 1949-09-19 1952-04-29 Hudson Bay Mining & Smelting Selective flotation of zinc
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
CN1162917A (zh) * 1994-10-07 1997-10-22 伯温德药品服务公司 肠内涂层组合物，用其涂覆的方法和涂覆制品
ATE286394T1 (de) * 1995-09-21 2005-01-15 Pharma Pass Ii Llc Ein säurelabile omeprazol enthaltende arzneizusammensetzung und verfahren zu deren herstellung
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
CN1216596C (zh) * 2000-02-10 2005-08-31 Bpsi控股公司 丙烯酸肠溶性涂层组合物
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US6703004B2 (en) * 2002-04-03 2004-03-09 Revlon Consumer Products Corporation Method and compositions for bleaching hair
US20040255399A1 (en) * 2003-06-23 2004-12-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method and compositions for coloring hair with taurate copolymers

Also Published As

Publication number Publication date
AR051722A1 (es) 2007-01-31
US20060134216A1 (en) 2006-06-22
IL183579A0 (en) 2007-09-20
JP2008524257A (ja) 2008-07-10
CN101080217A (zh) 2007-11-28
WO2006066264A1 (en) 2006-06-22
BRPI0518575A2 (pt) 2009-04-28
EP1827390A1 (en) 2007-09-05
CA2586425A1 (en) 2006-06-22
ZA200704311B (en) 2008-06-25
TW200626185A (en) 2006-08-01
CN101080217B (zh) 2012-07-18
KR20070094627A (ko) 2007-09-20
AU2005316235A1 (en) 2006-06-22
MX2007007221A (es) 2007-08-14

Similar Documents

Publication Publication Date Title
NO20073395L (no) Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer
MXPA05008491A (es) Sistemas de recubrimiento de pelicula nacarada y substratos recubiertos con la misma.
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
MA34104B1 (fr) Revêtements améliorés à faible teneur en dioxyde de titane
EP2261236A3 (en) Composition for proteasome inhibition
MX2008013040A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1.
MX2009002229A (es) Benzotriazoles como moduladores de cinasas.
MX2009009948A (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa.
NO20083309L (no) Dynamiske terskler for betingede formater
UA94052C2 (uk) Похідні піридазину
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
UA94964C2 (ru) Производные 5-замещенного хиназолинона, композиция, которая их содержит, и их применение
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
NO20075046L (no) Gastroresistente farmasoytiske formuleringer inneholdende rifaximin
BRPI0309142C1 (pt) suspensão de microcápsulas em uma fase líquida aquosa, que permite a liberação modificada de pelo menos um princípio ativo com exclusão da amoxicilina e que é destinada a ser administrada por via oral
EP2184984A4 (en) DERIVATIVES OF N- (ARYLAMINO) SULPHONAMIDES WITH POLYMORPHES AS MEK-INHIBITORS AND COMPOSITIONS THEREOF, METHOD FOR THEIR USE AND METHOD FOR THEIR PREPARATION
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
BRPI0719393B8 (pt) composição farmacêutica
BRPI0714417B8 (pt) método para fabricar uma composição de cuidado oral, de cuidado pessoal, limpadora e/ou de cuidado doméstico
NO20080002L (no) Formuleringer av konjugerte ostrogener og bazedoxifen
NO20076515L (no) Hydantoinforbindelser
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
MX2010004501A (es) Inhibidor de la proteina de activacion de 5-lipoxigenasa (plap).
MX2009012203A (es) Tratamiento de distrofia muscular de duchenne.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application